Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032
ONCYOncolytics Biotech (ONCY) Prnewswire·2024-05-04 00:15

USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, May 3, 2024 /PRNewswire/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further alarm is being spread by the United Nations, whose health authorities are predicting global cancer cases to rise around 77% by 2050, with richer countries expected to have the greatest absolute increase in cancer, with an additional 4.8 million new cas ...